Screener
Ultragenyx Pharmaceutical RARE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's short-term investments?
- Ultragenyx Pharmaceutical (RARE) reported short-term investments of $167M in Q2 2026.
- How has Ultragenyx Pharmaceutical's short-term investments changed year-over-year?
- Ultragenyx Pharmaceutical's short-term investments decreased by 46.4% year-over-year, from $311.28M to $167M.
- What is the long-term trend for Ultragenyx Pharmaceutical's short-term investments?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's short-term investments has grown at a -11.9% compound annual growth rate (CAGR), from $488.01M to $259M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Ultragenyx Pharmaceutical's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude